Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Avacta Group Share Price
  4. Avacta Group Share Regulatory News
  5. Issue of Equity

Pin to quick picksAvacta Group Regulatory News (AVCT)

Avacta Group Information

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
68.50    -2.00 (-2.84%)
Bid:
68.00
Ask:
69.00
Spread: 1.00 (1.471%)
Market Cap: £320.96m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Issue of Equity

10 Jul 2009 16:17

RNS Number : 5118V
Avacta Group PLC
10 July 2009
 



Avacta Group plc

Issue of Equity

Avacta Group plc (the "Company") announces that 750,700 ordinary shares of 0.1p each ("Ordinary Shares")  have been issued at an average price of 1.93 pence per share pursuant to contractual obligations  for services provided to the Company. 

Application has been made for 750,700 new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 17 July 2009.

The total number of Ordinary Shares in issue following the above issue will be 1,152,502,071.

Enquiries:

Avacta Group plc
Tim Sykes, Chief Financial Officer
 
Tel: 087 0835 4367
Daniel Stewart & Company Plc
Simon Leathers/Charlotte Stranner
 
Tel: 020 7776 6550
Novum Securities Limited
Henry Turcan
 
Tel: 020 7562 4700

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEURAVRKORBAAR
789101112131415
Date   Source Headline
12th Nov 20187:00 amRNSAvacta to Present at Major European Conference
11th Oct 20187:00 amRNSAvacta's CTO to Present at Major US Conference
10th Oct 20187:00 amRNSAvacta agrees Affimer reagent licensing deal
2nd Oct 20187:00 amRNSPreliminary Results
21st Sep 20187:00 amRNSInvestor Meeting and Presentation
5th Sep 20187:15 amEQSHardman & Co Research: Avacta (AVCT): Capital increase for further development
5th Sep 20187:00 amRNSNotice of Results
31st Aug 20189:55 amRNSHolding(s) in Company
23rd Aug 20185:07 pmRNSHolding(s) in Company
23rd Aug 20185:06 pmRNSHolding(s) in Company
23rd Aug 201811:21 amRNSHolding(s) in Company
22nd Aug 20182:23 pmRNSHolding(s) in Company
22nd Aug 20189:20 amRNSHolding(s) in Company
17th Aug 201811:30 amRNSResult of General Meeting
6th Aug 20184:24 pmRNSHolding(s) in Company
30th Jul 20186:06 pmRNSResults of Placing and Subscription
30th Jul 201811:41 amRNSProposed Placing and Subscription to raise £11.4m
30th Jul 201810:35 amEQSHardman & Co Research: Avacta (AVCT): Ground-breaking new drug conjugate platform
24th Jul 20187:00 amRNSMajor Therapeutics Co-development Partnership
26th Jun 20181:30 pmEQSHardman & Co Research: Avacta (AVCT): Gearing up the management team
11th Jun 20187:00 amRNSAppointment of Non-Executive Chairman
31st May 201812:15 pmEQSHardman & Co Research: Avacta (AVCT): In vivo expression of Affimers
22nd May 20187:00 amRNSSuccessful Outcome of Study with FIT Biotech
30th Apr 20184:45 pmRNSHolding(s) in Company
17th Apr 20187:17 amEQSHardman & Co Research: Avacta (AVCT): Commendable rate of progress
16th Apr 20187:25 amRNSInterim Results
9th Apr 20182:58 pmRNSIssue of Equity
29th Mar 20187:00 amRNSAvacta to Present at Investor Forum
29th Mar 20187:00 amRNSDirectorate Change
13th Mar 201812:02 pmRNSDirector/PDMR Shareholding
7th Mar 20184:35 pmRNSPrice Monitoring Extension
8th Feb 20187:00 amRNSSummary of Capital Markets Day
22nd Jan 20187:00 amRNSAvacta and OncoSec to Collaborate
18th Jan 201811:26 amRNSResult of Annual General Meeting
18th Jan 20187:00 amRNSAGM Business Update and Notice of Results
15th Jan 201810:58 amRNSHardmanResearch: Affimer Drug Conjugates a reality
15th Jan 20187:00 amRNSDrug Development Partnership with Glythera
8th Jan 20187:00 amRNSCapital Markets Day Notification
4th Jan 201811:04 amRNSPDMR Dealing and Issue of Equity
3rd Jan 20187:00 amRNSPresenting at the Biotech Showcase, San Francisco
18th Dec 20174:28 pmRNSIssue of Equity
4th Dec 201711:03 amRNSPosting of Annual Report and Notice of AGM
30th Nov 201710:57 amRNSIssue of Equity
15th Nov 20177:00 amRNSCovance to Present Affimer Data at Conference
14th Nov 20173:27 pmRNSHolding(s) in Company
13th Nov 20177:00 amRNSAvacta to Present at Investor Evening
13th Nov 20177:00 amRNSAvacta to present at PEGS Europe
24th Oct 20177:00 amRNSAffimers in Scientific Publications
19th Oct 20177:00 amRNSPrivate Shareholder Update Event
16th Oct 201710:42 amRNSHardman Res.: R&D accelerated to advance assets
789101112131415

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
PSON
Pearson
LSE
0.40%
HHI
Henderson High Income Trust
LSE
-0.38%
MNG
M&G
LSE
0.58%
JUST
Just Group
LSE
0.00%
NG.
National Grid
LSE
-0.33%
Trending
PREM
Premier African Minerals
LSE
-2.78%
GST
GSTechnologies
LSE
4.04%
QED
Quadrise
LSE
1.01%
CPI
Capita
LSE
3.62%
NTVO
Nativo Resources
LSE
4.55%